Yahoo
NYSE - Nasdaq Real Time Price USD

Teleflex Incorporated (TFX)

125.87 +0.91 (+0.73%)
As of 9:57:58 AM EDT. Market Open.
Trade TFX on Coinbase
Chart Range Bar
Loading chart for TFX

News headlines Teleflex (NYSE: TFX) reported a 32.3% year-over-year revenue increasein Q1 2026, but mixed signals in earnings guidance raise concerns. The company is navigating high debt levels and ongoing restructuring efforts while the market faces geopolitical risks and pricing pressures.

Teleflex (NYSE: TFX) reported a 32.3% year-over-year revenue increasein Q1 2026, but mixed signals in earnings guidance raise concerns. The company is navigating high debt levels and ongoing restructuring efforts while the market faces geopolitical risks and pricing pressures.

Updated 5m ago · Powered by Yahoo Scout
  • Previous Close 124.96
  • Open 125.50
  • Bid 124.43 x 20000
  • Ask 126.23 x 10000
  • Day's Range 124.29 - 126.23
  • 52 Week Range 100.18 - 139.67
  • Volume 10,444
  • Avg. Volume 796,290
  • Market Cap (intraday) 5.572B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 2,097.83
  • EPS (TTM) 0.06
  • Earnings Date (est.) Jul 30, 2026
  • Forward Dividend & Yield 1.36 (1.06%)
  • Ex-Dividend Date May 22, 2026
  • 1y Target Est 145.89

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

www.teleflex.com

15,500

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 6/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TFX
3.70%
S&P 500 (^GSPC)
9.14%

1-Year Return

TFX
8.15%
S&P 500 (^GSPC)
24.92%

3-Year Return

TFX
48.81%
S&P 500 (^GSPC)
69.43%

5-Year Return

TFX
67.12%
S&P 500 (^GSPC)
79.32%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 548.26M
Earnings 61.6M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
200M
400M
600M
800M

Analyst Insights

View More

Analyst Price Targets

135.00
145.89 Average
125.87 Current
160.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/8/2026
Analyst Piper Sandler
Rating Action Upgrade
Rating Overweight
Price Action Raises
Price Target 140 -> 160

Statistics

View More

Valuation Measures

Annual
As of 6/17/2026
  • Market Cap

    5.53B

  • Enterprise Value

    7.91B

  • Trailing P/E

    2.08k

  • Forward P/E

    18.94

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.60

  • Price/Book (mrq)

    1.79

  • Enterprise Value/Revenue

    3.72

  • Enterprise Value/EBITDA

    30.16

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -47.43%

  • Return on Assets (ttm)

    2.33%

  • Return on Equity (ttm)

    0.04%

  • Revenue (ttm)

    2.13B

  • Net Income Avi to Common (ttm)

    1.36M

  • Diluted EPS (ttm)

    0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    333.06M

  • Total Debt/Equity (mrq)

    88.79%

  • Levered Free Cash Flow (ttm)

    -3.68M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

125.87 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Lowering target price to $134.00

    TELEFLEX INC has an Investment Rating of HOLD; a target price of $134.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
  • Raising target price to $143.00

    TELEFLEX INC has an Investment Rating of HOLD; a target price of $143.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
  • Lowering target price to $132.00

    TELEFLEX INC has an Investment Rating of HOLD; a target price of $132.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • Lowering target price to $138.00

    TELEFLEX INC has an Investment Rating of HOLD; a target price of $138.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: